Spur Therapeutics
Founded 2015 · 278 employees on LinkedIn · 3 known investors
Find your way into Spur Therapeutics
Sign up to find every way you can get introduced to Spur Therapeutics
- Your email: who you already know at Spur Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Spur Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Spur Therapeutics develops gene therapy treatments for genetic diseases, aiming to bring genetic medicine therapies to patients worldwide.
Founders & leadership
Board
C
ChrisChair (until August 2026), Chief Executive Officer
Investors · 3
Frequently asked questions
- What does Spur Therapeutics do?
- Spur Therapeutics develops gene therapy treatments for genetic diseases, aiming to bring genetic medicine therapies to patients worldwide.
- Who are Spur Therapeutics's investors?
- Spur Therapeutics's investors include Syncona, AlbionVC, UCL Technology Fund.


